Europe's STOXX 600 gains as earnings flourish; focus on Fed decision

Published 07/30/2024, 03:38 AM
Updated 07/30/2024, 12:42 PM
© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, July 29, 2024. REUTERS/Staff/File Photo

By Shashwat Chauhan and Pranav Kashyap

(Reuters) -European shares closed higher on Tuesday, boosted by earnings-driven gains across several pockets of the market, with focus squarely on the Federal Reserve's upcoming rate verdict and the subsequent outlook for monetary policy.

The pan-European STOXX 600 index finished 0.5% higher, with the euro zone bank index up 1.2%, one of the top gainers among the major STOXX sectors.

Intesa Sanpaolo (OTC:ISNPY) jumped 3.5% after Italy's biggest bank raised its profit outlook, posting stronger than expected quarterly earnings and signalling additional investor rewards ahead.

Raiffeisen Bank International added 3.7% after the Austrian lender beat estimates on second quarter profit.

Construction and materials gained 1.3% with Spanish builder ACS up more than 4% after reporting a 8% rise in first-half net profit.

On the data front, the euro zone economy grew slightly more than expected in the three months to June, but a mixed underlying picture and a string of pessimistic surveys cloud the outlook for the rest of the year.

"With yet another small upside surprise to the GDP data, there is also a case to aim off the surveys a bit," Simon Wells, chief European economist at HSBC, wrote in a note.

"With growth broadly at trend and inflation heading only slowly to target, there is little evidence to suggest that monetary policy is highly restrictive."

Data showed the German economy unexpectedly contracted in the second quarter after skirting a recession at the beginning of the year, with a rise in inflation in July, underlining the continuing struggles of the euro zone's biggest economy.

Investor focus this week will remain on the Federal Reserve, which concludes its two-day rate-setting meeting on Wednesday, with investors anticipating a signal that it could start cutting interest rates in September.

The Bank of England (BoE) will also announce its latest verdict on monetary policy later this week.

Among other headlining stocks, Novo Nordisk (NYSE:NVO) gained 1.4% after the Danish obesity drugmaker posted a study showing Ozempic reduced tobacco-related health complications among smoking patients with type 2 diabetes.

Britain's St James's Place surged 24.8% to the top of the STOXX 600 after the wealth manager outlined a six-year plan to slash costs and revamp its services.

Poste Italiane advanced 4.3% as the state-owned postal service group slightly raised its full-year profit goal after operating profit fell less than anticipated in the second quarter.

On the flipside, Britain's Diageo (LON:DGE) slid 5.1% as the world's top spirits maker warned that challenges could persist into next year after it missed full-year profit expectations.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.